Antidepressants Market Report
RA02010
Antidepressants Market, by Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Others), Depression Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global antidepressants market is estimated to surpass $25,314.5 million by 2027, exhibiting a CAGR of 14.3% from 2020 to 2027.
The report provides all-inclusive analysis of global antidepressants market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
The report emphasizes current market scenario and future trends of the global antidepressants market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global antidepressants market.
In addition, the report provides market size and forecast scrutinizing global antidepressants market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global antidepressants market. In the report, the global antidepressants market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover antidepressants market landscape in respective regions.
Furthermore, competitive scenario of the global antidepressants market is covered in the report. Major players functioning in the global antidepressants market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global antidepressants market, and others.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global antidepressants market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
KEY MARKET BENEFITS
- This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
- The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global antidepressants market growth.
- The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
- The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the antidepressants market.
- The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global antidepressants market.
KEY MARKET SEGMENTS
The market has been studied based on the following segments:
- Product: Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Others
- Depression Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, Others
Region:
The global antidepressants market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The report covers the major players operating in the global antidepressants market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Intra-Cellular Therapies, Allergan Plc, Opko Health, Teva Pharmaceutical Industries Ltd., …., and others.
The report summarizes various aspects of all these key players that include as follows:
1. Alkermes Plc
2. Allergan Plc
3. Bristol Myers Squibb Co.
4. Eli Lilly And Co.
5. Glaxosmithkline Plc
6. H. Lundbeck
7. Merck & Co., Inc.
8. Pfizer Inc.
9. Teva Pharmaceutical Industries Ltd.
10. Takeda Pharmaceutical Co. Ltd
11. Opko Health
12. Intra-Cellular Therapies
13. Janssen Pharmaceuticals
14. Lupin
15.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Antidepressants Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Antidepressants Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Antidepressants Market, By Product
5.1. Overview
5.2 Tricyclic Antidepressants
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Selective Serotonin Reuptake Inhibitors
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Serotonin-Norepinephrine Reuptake Inhibitors
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Monoamine Oxidase Inhibitors
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Serotonin Antagonist And Reuptake Inhibitors
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Others
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Research Dive Exclusive Insights
5.8.1 Market attractiveness
5.8.2 Competition heatmap
-
6. Antidepressants Market, By Form
6.1. Overview
6.2 Major Depressive Disorder
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Obsessive-Compulsive Disorder
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Generalized Anxiety Disorder
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Panic Disorder
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
7. Antidepressants Market, By Region
7.1 North America
7.1.1 U.S
7.1.1.1 Market size analysis, By Product, 2020-2027
7.1.1.2 Market size analysis, By Form, 2020-2027
7.1.2 Canada
7.1.2.1 Market size analysis, By Product, 2020-2027
7.1.2.2 Market size analysis, By Form, 2020-2027
7.1.3 Mexico
7.1.3.1 Market size analysis, By Product, 2020-2027
7.1.3.2 Market size analysis, By Form, 2020-2027
7.1.4 Research Dive Exclusive Insights
7.1.4.1 Market attractiveness
7.1.4.2 Competition heatmap
7.2 Europe
7.2.1 Germany
7.2.1.1 Market size analysis, By Product, 2020-2027
7.2.1.2 Market size analysis, By Form, 2020-2027
7.2.2 UK
7.2.2.1 Market size analysis, By Product, 2020-2027
7.2.2.2 Market size analysis, By Form, 2020-2027
7.2.3 France
7.2.3.1 Market size analysis, By Product, 2020-2027
7.2.3.2 Market size analysis, By Form, 2020-2027
7.2.4 Spain
7.2.4.1 Market size analysis, By Product, 2020-2027
7.2.4.2 Market size analysis, By Form, 2020-2027
7.2.5 Italy
7.2.5.1 Market size analysis, By Product, 2020-2027
7.2.5.2 Market size analysis, By Form, 2020-2027
7.2.6 Rest of Europe
7.2.6.1 Market size analysis, By Product, 2020-2027
7.2.6.2 Market size analysis, By Form, 2020-2027
7.2.7 Research Dive Exclusive Insights
7.2.7.1 Market attractiveness
7.2.7.2 Competition heatmap
7.3 Asia-Pacific
7.3.1 China
7.3.1.1 Market size analysis, By Product, 2020-2027
7.3.1.2 Market size analysis, By Form, 2020-2027
7.3.2 Japan
7.3.2.1 Market size analysis, By Product, 2020-2027
7.3.2.2 Market size analysis, By Form, 2020-2027
7.3.3 India
7.3.3.1 Market size analysis, By Product, 2020-2027
7.3.3.2 Market size analysis, By Form, 2020-2027
7.3.4 Australia
7.3.4.1 Market size analysis, By Product, 2020-2027
7.3.4.2 Market size analysis, By Form, 2020-2027
7.3.5 South Korea
7.3.5.1 Market size analysis, By Product, 2020-2027
7.3.5.2 Market size analysis, By Form, 2020-2027
7.3.6 Rest of Asia-Pacific
7.3.6.1 Market size analysis, By Product, 2020-2027
7.3.6.2 Market size analysis, By Form, 2020-2027
7.3.7 Research Dive Exclusive Insights
7.3.7.1 Market attractiveness
7.3.7.2 Competition heatmap
7.4 LAMEA
7.4.1 Brazil
7.4.1.1 Market size analysis, By Product, 2020-2027
7.4.1.2 Market size analysis, By Form, 2020-2027
7.4.2 Saudi Arabia
7.4.2.1 Market size analysis, By Product, 2020-2027
7.4.2.2 Market size analysis, By Form, 2020-2027
7.4.3 UAE
7.4.3.1 Market size analysis, By Product, 2020-2027
7.4.3.2 Market size analysis, By Form, 2020-2027
7.4.4 South Africa
7.4.4.1 Market size analysis, By Product, 2020-2027
7.4.4.2 Market size analysis, By Form, 2020-2027
7.4.5 Rest of LAMEA
7.4.5.1 Market size analysis, By Product, 2020-2027
7.4.5.2 Market size analysis, By Form, 2020-2027
7.4.6 Research Dive Exclusive Insights
7.4.6.1 Market attractiveness
7.4.6.2 Competition heatmap
8. Competitive Landscape
8.1 Top winning strategies, 2020-2027
8.1.1 By strategy
8.1.2 By year
8.2 Strategic overview
8.3 Market share analysis, 2020-2027
9. Company Profiles
9.1 Alkermes Plc
9.1.1 Overview
9.1.2 Business segments
9.1.3 Product portfolio
9.1.4 Financial performance
9.1.5 Recent developments
9.1.6 SWOT analysis
9.2 Allergan Plc
9.2.1 Overview
9.2.2 Business segments
9.2.3 Product portfolio
9.2.4 Financial performance
9.2.5 Recent developments
9.2.6 SWOT analysis
9.3 Bristol Myers Squibb Co.
9.3.1 Overview
9.3.2 Business segments
9.3.3 Product portfolio
9.3.4 Financial performance
9.3.5 Recent developments
9.3.6 SWOT analysis
9.4 Eli Lilly And Co.
9.4.1 Overview
9.4.2 Business segments
9.4.3 Product portfolio
9.4.4 Financial performance
9.4.5 Recent developments
9.4.6 SWOT analysis
9.5 Glaxosmithkline Plc
9.5.1 Overview
9.5.2 Business segments
9.5.3 Product portfolio
9.5.4 Financial performance
9.5.5 Recent developments
9.5.6 SWOT analysis
9.6 H. Lundbeck
9.6.1 Overview
9.6.2 Business segments
9.6.3 Product portfolio
9.6.4 Financial performance
9.6.5 Recent developments
9.6.6 SWOT analysis
9.7 Merck & Co., Inc.
9.7.1 Overview
9.7.2 Business segments
9.7.3 Product portfolio
9.7.4 Financial performance
9.7.5 Recent developments
9.7.6 SWOT analysis
9.8 Pfizer Inc.
9.8.1 Overview
9.8.2 Business segments
9.8.3 Product portfolio
9.8.4 Financial performance
9.8.5 Recent developments
9.8.6 SWOT analysis
9.9 Teva Pharmaceutical Industries Ltd.
9.9.1 Overview
9.9.2 Business segments
9.9.3 Product portfolio
9.9.4 Financial performance
9.9.5 Recent developments
9.9.6 SWOT analysis
9.10 Takeda Pharmaceutical Co. Ltd
9.10.1 Overview
9.10.2 Business segments
9.10.3 Product portfolio
9.10.4 Financial performance
9.10.5 Recent developments
9.10.6 SWOT analysis
9.11 Opko Health
9.11.1 Overview
9.11.2 Business segments
9.11.3 Product portfolio
9.11.4 Financial performance
9.11.5 Recent developments
9.11.6 SWOT analysis
9.12 Intra-Cellular Therapies
9.12.1 Overview
9.12.2 Business segments
9.12.3 Product portfolio
9.12.4 Financial performance
9.12.5 Recent developments
9.12.6 SWOT analysis
9.13 Janssen Pharmaceuticals
9.13.1 Overview
9.13.2 Business segments
9.13.3 Product portfolio
9.13.4 Financial performance
9.13.5 Recent developments
9.13.6 SWOT analysis
9.14 Lupin
9.14.1 Overview
9.14.2 Business segments
9.14.3 Product portfolio
9.14.4 Financial performance
9.14.5 Recent developments
9.14.6 SWOT analysis
9.15
9.15.1 Overview
9.15.2 Business segments
9.15.3 Product portfolio
9.15.4 Financial performance
9.15.5 Recent developments
9.15.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
